Montpellier, France

Jawida Lezaar


Average Co-Inventor Count = 7.5

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jawida Lezaar

Introduction

Jawida Lezaar is a notable inventor based in Montpellier, France. He has made significant contributions to the field of biomedical research, particularly in the diagnosis and treatment of diseases related to transporters. With a total of two patents to his name, Lezaar's work is paving the way for advancements in medical diagnostics.

Latest Patents

Lezaar's latest patents include innovative methods for diagnosing and measuring levels of the sodium-dependent multivitamin transporter (SMVT) in biological samples. One patent focuses on the use of ligands derived from the receptor-binding domain of porcine endogenous retrovirus type B for diagnosing SMVT-related diseases. The methods involve contacting a biological sample with a PERV-B.RBD ligand and detecting the binding to SMVT. Another patent addresses the diagnosis and treatment of cationic l-amino acid transporter-related diseases using a receptor-binding domain derived from bovine leukemia virus. This patent discloses methods for detecting CAT1 in cells and offers a BLV.RBD ligand for treatment purposes.

Career Highlights

Throughout his career, Jawida Lezaar has worked with prominent organizations such as Metafora Biosystems and the Centre National De La Recherche Scientifique. His experience in these institutions has contributed to his expertise in the field of biomedical research and innovation.

Collaborations

Lezaar has collaborated with notable colleagues, including Marc Sitbon and Vincent Petit. These partnerships have likely enhanced his research and development efforts, leading to impactful innovations in his field.

Conclusion

Jawida Lezaar's contributions to biomedical research through his patents and collaborations highlight his role as an influential inventor. His work continues to advance the understanding and treatment of critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…